Sentence and cancer type
Showing 421-440 of 831 items.
SentenceCancertype
Ki-ras oncogene and p53 tumour suppressor gene mutations in colorectal carcinomas from the European Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model. colorectal,
Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis. pancreatic,
Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung. lung,
Mutations of K-ras oncogene in human adrenal tumours in Taiwan. kidney,
Analysis of K-ras oncogene mutation directly applied to atypical cell clusters on cytologic smear slides of bile and pancreatic juice. pancreatic,
Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression. gastric,
Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases. pancreatic,
Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma. colorectal,
K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients. cholangiocarcinoma,
K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium. liver,
Detection of Ki-ras oncogene mutations in pancreatic diseases: helpful or irrelevant?. pancreatic,
Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. lung,
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. lung,
Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. cholangiocarcinoma,
Complete cDNA sequence of the Ki-ras proto-oncogene in the liver of wild English sole (Pleuronectes vetulus) and mutation analysis of hepatic neoplasms and other toxicopathic liver lesions. liver,neoplasm,
It is proposed that lowering the affinity for GTP allows G12D Ras an escape from the oncogenic GTP-bound state, whereas GTP tightly bound to G12V mutant Ras generates a more persistent, potentially oncogenic, signal.None
Ki-ras oncogene mutations in chronic pancreatitis: which discriminating ability for malignant potential?. None
Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. None
Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase. None
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21. None